Liver regeneration in response to partial hepatectomy in rats treated with retrorsine: A kinetic study

Journal of Hepatology

Volumn 31, Issue 6, 1999, Pages 1069-1074

  Laconi, Sergio ^d   Curreli, Francesca ^d   Diana, Stefania ^d   Pasciu, Daniela ^d   Filippo, Greta De ^d   Sarma, Dittakavi S R ^b   Pani, Paolo ^d   Laconi, Ezio ^a,c  

^a Ospedale Oncologico A Businco   (Italy)

^b UNIVERSITY OF TORONTO   (Canada)

^c Dipartimento di Matematica e Informatica   (Italy)

^d NONE

Author keywords

Hepatocyte transplantation; Liver regeneration; Liver repopulation; Mitoinhibition; Pyrrolizidine alkaloids; Retrorsine

Indexed keywords

RETRORSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; KINETICS; LIVER CELL; LIVER REGENERATION; LIVER WEIGHT; MALE; MEGALOCYTOSIS; MITOSIS INDEX; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN CONTENT; RAT;

EID: 0032754852     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80320-1     Document Type: Article

References (18)

1. Laconi E, Sarma DSR, Pani P. Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis. 16:1995;139-142.
2. Laconi E, Oren R, Mukhopadhyay DK, Hurston E, Laconi S, Pani P, et al. Long term, near total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol. 153:1998;319-329.
3. Downing DT, Peterson JE. Quantitative assessment of the persistent antimitotic effect of certain hepatotoxic pyrrolizidine alkaloids on rat liver. Aust J Exp Biol Med Sci. 46:1968;493-502.
4. McLean E. The toxic actions of pyrrolizidine (senecio) alkaloids. Pharmacol Rev. 22:1970;429-483.
5. Jago MV. The development of the hepatic megalocytosis of chronic pyrrolizidine alkaloid poisoning. Am J Pathol. 56:1969;405-422.
6. Mattocks AR. Chemistry and Toxicology of Pyrrolizidine Alkaloids. 1986;Academic Press, Orlando, FL.
7. Samuel A, Jago MV. Localization in the cell cycle of the antimitotic action of the pyrrolizidine alkaloid, lasiocarpine and of its metabolite, dehydroheliotridine. Chem Biol Interact. 10:1975;185-197.
8. Peterson JE. Effects of the pyrrolizidine alkaloid lasiocarpine-N-oxide on nuclear and cell division in the liver of rats. J Pathol Bacteriol. 89:1965;153-171.
9. Hayes MA, Roberts E, Farber E. Initiation and selection of resistant hepatocyte nodules in rats given the pyrrolizidine alkaloids lasiocarpine and senecionine. Cancer Res. 45:1985;3726-3734.
10. Schoental R, Magee PN. Further observations on the subacute and chronic liver changes in rats after a single dose of various pyrrolizidine (senecio) alkaloids. J Pathol Bact. 78:1959;471-481.
11. Laconi E, Yusuf A, Jahangir AR, Laconi S, Rao PM, Rajalakshmi S, et al. Transient inhibition by orotic acid does not abolish the in vivo response of rat hepatocytes to a direct mitogen, lead nitrate. J Hepatol. 26:1997;203-208.
12. Lowry OH, Rosebrough NJ, Farr JL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem. 193:1951;265-275.
13. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of the cell cycle events. Science. 246:1989;629-634.
14. Handely S, Weintraub H. The ts41 mutation in Chinese hamster cells leads to successive S phases in the absence of intervening G2, M, and G1. Cell. 71:1992;599-611.
15. Le Page RN. Experimental studies with selective hepatotoxic agents. Ph.D. Thesis, University of Melbourne. 1963.
16. Reddy J, Harris C, Svoboda D. Inhibition by lasiocarpine of RNA synthesis, RNA polymerase and induction of tryptophan pyrrolase activity. Nature. 217:1968;659-661.
17. Bull LB, Dick AT. The chronic pathological effects on the liver of the rat of the pyrrolizidine alkaloids heliotrine, lasiocarpine, and their N-oxides. J Pathol Bacteriol. 78:1959;483-502.
18. Dabeva MD, Laconi E, Oren R, Petkov PM, Hurston E, Shafritz DA. Liver regeneration and alpha-fetoprotein messenger RNA expression in the retrorsine model of hepatocyte transplantation. Cancer Res. 58:1998;5825-5834.